Modular Medical Inc (OQ:MODD)
Business Focus: Medical Equipment, Supplies & Distribution
Mar 26, 2024 08:00 am ET
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the addition of Steve Gemmell as Vice President of Engineering.
Mar 04, 2024 08:00 am ET
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
SAN DIEGO, CA / ACCESSWIRE / March 4, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Revolutionizing Diabetes Care." The event is scheduled to begin at 8:00am pacific/11:00am eastern on Wednesday, March 6, 2024. To register to join the complime
Feb 21, 2024 04:05 pm ET
Modular Medical Announces Closing of $10 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, announced today the closing of its previously announced underwritten public offering (the "offering") of 9,090,910 shares of its common stock, led by Manchester Explorer, L.P., which is managed by Jeb Besser, Modular Medical's Chief Executive Officer, and Morgan Frank, a member of
Feb 15, 2024 08:45 pm ET
Modular Medical Announces Pricing of $10 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that it has priced its underwritten public offering (the "offering") of 9,090,910 shares of its common stock, led by Manchester Explorer, L.P., which is managed by Jeb Besser, Modular Medical's Chief Executive Officer, and Morgan Frank, a member of the Company's bo
Feb 15, 2024 04:15 pm ET
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical"), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that it has commenced an underwritten public offering (the "offering") of shares of its common stock (or pre-funded warrants to purchase shares of its common stock in lieu thereof). Modular Medical also intends to grant the underwriter a 30-day option to purchase up to an additional 15% of t
Jan 24, 2024 08:00 am ET
Modular Medical Announces Issuance of New US Patent
SAN DIEGO, CA / ACCESSWIRE / January 24, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the issuance of U.S. Patent 11,817,197 B2 for the stream-lined pairing of a pump to a mobile device.
Jan 19, 2024 08:31 am ET
Thinking about buying stock in Coffee Holding Co., Aquestive Therapeutics, Snowflake Inc, Mesoblast, or Modular Medical?
NEW YORK, Jan. 19, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JVA, AQST, SNOW, MESO, and MODD.
Jan 19, 2024 06:00 am ET
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
SAN DIEGO, CA / ACCESSWIRE / January 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the premarket submission of its MODD1 next-generation insulin pump to the FDA for 510(k) clearance.
Dec 21, 2023 08:00 am ET
Modular Medical Announces Collaboration with Glooko
SAN DIEGO, CA / ACCESSWIRE / December 21, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a collaboration agreement with Glooko, Inc., a global leader specializing in connected care and remote patient monitoring for diabetes. Integrating with Glooko will allow clinicians and patients to easily review insulin dosing data from the MODD1 pump, when commercially a
Dec 11, 2023 08:30 am ET
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes Care For The Rest Of Us." Featuring Modular Medical CEO On Friday, December 15, 2023
SAN DIEGO, CA / ACCESSWIRE / December 11, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Diabetes Care For The Rest Of Us." The event is scheduled to begin at 8:30am pacific/11:30am eastern on Friday, December 15, 2023. To register to join the
Nov 14, 2023 08:15 am ET
Modular Medical to Attend the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
SAN DIEGO, CA / ACCESSWIRE / November 14, 2023 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced it will be presenting at the Benchmark Company's 12th Annual Discovery One-on-One Investor Conference to be held Thursday, December 7, 2023 at the New York Athletic Club in New York City. Jeb Besser, CEO, is scheduled to host one-on-one meetings with analysts and investor
Oct 31, 2023 08:00 am ET
Modular Medical Updates Test Progress and Submission Timeline
SAN DIEGO, CA / ACCESSWIRE / October 31, 2023 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today provided an update on its ongoing pre-submission testing and timeline for submission of its MODD-1 insulin pump (the "MODD-1") to the U.S. Food and Drug Administration ("FDA"). The Company has made substantial progress on completing many of the tests required for
Aug 16, 2023 04:01 pm ET
Modular Medical Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives
SAN DIEGO, CA / ACCESSWIRE / August 16, 2023 / Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a collaboration under which Phillips-Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic, medtech and specialty consumer devices, is providing Modular Medical with design, development and high-volume manufacturing capabilities.
Aug 15, 2023 10:20 am ET
Sidoti Events, LLC’s Virtual August Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Aug 10, 2023 08:00 am ET
Modular Medical to Present at the Sidoti Micro-Cap Virtual Conference on August 17
SAN DIEGO, CA / ACCESSWIRE / August 10, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, CEO, is scheduled to present at the Sidoti Micro-Cap Virtual Conference on August 17. Mr. Besser will also host meetings with participating investors throughout the day during this virtual event.
Jul 06, 2023 08:30 am ET
Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors
SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the appointment of medical device industry leader Duane DeSisto to its board of directors. Mr. DeSisto was previously President, CEO and Director of Insulet Corporation, developers of the groundbreaking OmniPod Insulin Management System, before retiring in 2014.
May 25, 2023 04:05 pm ET
Modular Medical Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
SAN DIEGO, CA / ACCESSWIRE / May 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that the underwriter of the Company's previously announced public offering has exercised in full its option to purchase an additional 1,322,534 shares of its common stock and warrants to purchase 661,267 shares of its common stock. The warrants will be exercisable at $1.22 per sh
May 16, 2023 08:35 am ET
Modular Medical Announces Pricing of Upsized $9.4 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 16, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the pricing of an upsized underwritten public offering of 8,816,900 shares of its common stock and warrants to purchase 4,408,450 shares of its common stock. The securities are being sold as a unit, with each unit comprising two shares of common stock and one warrant to purchase
Jan 25, 2023 09:00 am ET
Modular Medical Provides Update on FDA Submission Strategy
SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today provided an update on its insulin pump product.
Nov 28, 2022 09:29 am ET
Modular Medical Announces Product Testing Update
SAN DIEGO, CA / ACCESSWIRE / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced an update on the development of its initial insulin pump product.
Nov 23, 2022 11:20 am ET
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences:
Oct 03, 2022 06:00 am ET
Modular Medical Provides Product Update
SAN DIEGO, CA / ACCESSWIRE / October 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today provided an update on its insulin pump product.
Sep 07, 2022 08:00 am ET
Modular Medical Announces Participation at Upcoming Investor Conferences
SAN DIEGO, CA / ACCESSWIRE / September 7, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences:
Aug 11, 2022 08:30 am ET
Dr. Anne Peters Joins the Modular Medical Advisory Board
Dr. Peters, a prominent diabetes clinician and clinical researcher, is a leading voice in the fight to bring diabetes technology and therapeutics to under-resourced communities
Jul 26, 2022 08:15 am ET
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing
Jun 02, 2022 04:01 pm ET
Modular Medical to Present at LD Micro Invitational XII Investor Conference
SAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, is scheduled to present at the LD Micro Invitational XII Investor Conference on Wednesday, June 8, 2022 at 3:30 PM PT, at the Four Seasons Hotel in Westlake Village, California.
May 16, 2022 01:20 pm ET
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
May 12, 2022 04:00 pm ET
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022
SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, CEO, is scheduled to present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022 at 1:00 p.m. ET. Mr. Besser will also host meetings with participating investors throughout the day during this virtual event. The presentation will be webcast live and availabl
May 03, 2022 08:00 am ET
Modular Medical Announces $8 Million Registered Direct Offering
SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with institutional investor Sio Capital Management (the "Investor") in connection with a registered direct offering of an aggregate of 449,438 shares of its common stock at an offering price of $4.45 per share, and, in lieu of common stock, pre-funded warrants to purchase up to 1,348,314 shares of common stock at an offering price of $4.44 per pre-funded warran
Mar 03, 2022 04:01 pm ET
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
SAN DIEGO, CA / ACCESSWIRE / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that the Company will present at Oppenheimer's 32nd Annual Healthcare Conference. Jeb Besser, the Company's Chief Executive Officer, will represent the Company in a virtual session scheduled to begin at 8:40 am Eastern Time on March 15, 2022.
Feb 24, 2022 08:00 am ET
Modular Medical Appoints James "Jeb" Besser as Chief Executive Officer
Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FDA
Feb 10, 2022 08:00 am ET
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market
SAN DIEGO, CA / ACCESSWIRE / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, announced today the pricing of its underwritten public offering of 2,500,000 units at a price to the public of $6.00 per unit, for aggregate gross proceeds of $15 million, prior to deducting underwriting discounts, commissi
Nov 29, 2021 08:00 am ET
Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.
SAN DIEGO, CA / ACCESSWIRE / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced the expansion of its Board of Directors with the appointment of two independent directors, Steven G. Felsher and Philip B. Sheibley.
Nov 26, 2021 02:40 pm ET
Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market
SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity to increase pump adoption and reduce the burden of diabetes care for clinicians and individuals living with diabetes, today announced a "reverse split" of its shares of common stock at a ratio of 1-for-3. The Company's common stock will begin trading on a post-split basis on Monday, November 29, 2021 under the trading symbol "MODDD." The "D"
Aug 16, 2021 09:00 am ET
Modular Medical Expands Executive Team with Appointment Of Lynn O'Connor Vos as New CEO
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient Advocacy
Jun 07, 2021 09:00 am ET
Encode Ideas, L.P. Announces the Initiation of Research Coverage on Modular Medical, Inc.
Dover, Delaware--(Newsfile Corp. - June 7, 2021) - Encode Ideas, L.P. Initiates Research on Modular Medical, Inc. (OTCQB: MODD). The full research publication can be found on our website at www.encodelp.com.
May 25, 2021 08:00 am ET
Modular Medical Welcomes Global Healthcare Leader Lynn Vos to its Board of Directors
SAN DIEGO, CA / ACCESSWIRE / May 25, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, is pleased to announce the appointment of industry veteran Lynn O'Connor Vos to its board of directors.
May 12, 2021 04:00 pm ET
Modular Medical Announces Financing
SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Modular Medical, Inc. (OTCQB:MODD), a medical device company focused on next generation insulin delivery technologies to widen the accessibility of insulin pumps to a greater share of people with type 1 and type 2 diabetes, announced today that it has entered into definitive agreements for a private placement of $6.6 million of convertible promissory notes.
Mar 18, 2021 09:00 am ET
Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory Board
A group of prominent health care professionals and experts in the use and development of diabetes technology brings extensive insights across the spectrum of patient care
Mar 16, 2021 08:30 am ET
Modular Medical Relocates to Larger Corporate Headquarters
The 7,300 square foot facility features a clean-room manufacturing environment and environmentally controlled test labs
Feb 18, 2021 02:35 pm ET
Modular Medical Uplists to OTCQB Venture Market
SAN DIEGO, CA / ACCESSWIRE / February 18, 2021 / Modular Medical, Inc. (OTCQB:MODD), a development-stage company in the diabetes/insulin delivery space, today announced its successful uplisting to the OTCQB® Venture Market. Modular Medical's common stock will continue to trade under the ticker "MODD."
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.